ZBiotics Secures $12 Million in Series A Funding to Expand Revolutionary Probiotic Line

ZBiotics, a trailblazer in the realm of genetically engineered probiotics, has successfully concluded its $12 million Series A funding round. The investment, led by Spring Tide Capital and supported by Access Capital, Seamless Capital, Goat Rodeo Capital, and Seaside Ventures, marks a significant milestone for the company. The funds are set to fuel ZBiotics‘ plans…

Read More

Semrush Expands Digital Footprint with Acquisition of German SaaS Pioneer Ryte

Semrush Holdings, a global leader in online visibility management, has announced its acquisition of Ryte, a prominent Munich-based SaaS company known for its expertise in optimizing website user experience. This strategic move marks a significant expansion for Semrush, further strengthening its capabilities in SEO and digital marketing solutions. Founded in 2012, Ryte has made a…

Read More

Redefining Mobility: ATDev’s $3 Million Seed Round Powers Next-Gen Assistive Tech for Independent Living

In a market ripe for disruption, Assistive Technology Development, Inc. (ATDev) is carving a distinct path forward with its AI-driven rehabilitation and mobility solutions. The Orange, California–based startup recently closed a $3 million seed round led by Dobrzelecki Legacy Ventures, alongside contributions from Uphonest Capital, The Life Science Angels, and a consortium of industry veterans….

Read More

Naked Energy Secures £17M to Accelerate Global Expansion of Heat Decarbonisation Solutions

British design and engineering firm Naked Energy has successfully secured £17 million in a Series B funding round, marking a pivotal moment in its mission to advance heat decarbonisation on a global scale. The latest infusion of capital will drive the company’s expansion efforts and enhance its innovative solutions designed to mitigate heat emissions effectively….

Read More
Jeanne Volatron, Co-Founder and CEO of EVerZom Nicolas Rousseau

EVerZom Secures €10M to Advance Groundbreaking Exosome-Based Biotherapies for Inflammatory Diseases

EVerZom, a pioneering biotechnology firm based in France, has secured €10 million in a Series A funding round to propel the clinical development of its first therapeutic candidate and further scale its exosome biomanufacturing platform. The investment, which brings together major players like Capital Grand Est, the European Innovation Council (EIC) Fund, Sorbonne Venture by…

Read More

Safire Group Secures $8 Million to Elevate Lithium-ion Battery Safety Standards

In a significant move for the energy safety sector, Safire Technology Group, Inc. has announced the successful completion of an $8 million financing round led by Canaan Partners, marking a pivotal step in the company’s mission to enhance the safety of lithium-ion (Li-ion) batteries across government and automotive markets. This Pre-Series A financing round, which…

Read More
Verisoul CEO and co-founder, Henry LeGard

Verisoul Secures $8.8 Million Series A to Fortify Digital Trust Against the AI-Driven Fraud Onslaught

In a decisive move to combat the surging tide of sophisticated, AI-fueled digital fraud, Verisoul has successfully closed an $8.8 million Series A funding round. The infusion of capital is set to significantly boost the Austin-based company’s mission to become the single source of truth for user integrity in the digital world. The investment round…

Read More

Innatera Surges Ahead: Secures $21M Series A Funding to Propel Innovation in Neuromorphic Processors

In a resounding endorsement of its pioneering work in neuromorphic computing, Innatera has announced the successful closure of its oversubscribed Series A funding round, securing a substantial $21 million. This funding round, led by Innavest and InvestNL with participation from esteemed investors including EIC Fund and Matterwave Ventures, marks a pivotal moment for the Delft-based…

Read More
Dr. Mark Lee, M.D., Ph.D., N-Power Medicine

N-Power Medicine Raises $72M in Series B Funding to Advance Oncology Clinical Trials Platform

N-Power Medicine, a trailblazer in redefining the clinical trial landscape, has announced a significant milestone with the closure of its Series B funding round, securing $72 million in total funding. Led by the Merck Global Health Innovation Fund, alongside a prominent U.S.-based healthcare investor, this funding infusion marks a pivotal moment for N-Power Medicine as…

Read More

Mem0 Raises $24M to Build the Memory Layer Powering the Next Generation of AI Agents

In the heart of San Francisco’s fast‑moving AI infrastructure scene, Mem0 has quietly positioned itself at a critical juncture. Facing the problem that many large language models (LLMs) simply forget what happened in prior interactions, Mem0 is forging a new layer that remembers — turning every chat, every prompt, and every session into enduring context. The…

Read More